Revenue

6 Months Ended

Jun. 30, 2024

Revenue Recognition [Abstract]

Revenue

3. Revenue

Net sales by geography are as follows (in millions):

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2024		2023		2024		2023
United States	$	1,106.2	$	1,068.9	$	2,205.4	$	2,129.2
International		835.8		800.7		1,625.8		1,571.4
Total	$	1,942.0	$	1,869.6	$	3,831.2	$	3,700.6

Net sales by product category are as follows (in millions):

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2024		2023		2024		2023
Knees	$	801.1	$	771.4	$	1,589.3	$	1,533.9
Hips		506.5		504.3		997.6		997.1
S.E.T.		469.5		442.7		922.1		876.1
Other		164.9		151.2		322.2		293.5
Total	$	1,942.0	$	1,869.6	$	3,831.2	$	3,700.6

S.E.T. includes sales from our Sports Medicine, Extremities, Trauma, Craniomaxillofacial and Thoracic ("CMFT") product categories. Other includes sales from our Technology, Surgical and Bone Cement product categories.

This net sales presentation differs from our reportable operating segments, which are based upon our senior management organizational structure and how we allocate resources toward achieving operating profit goals. Each of our reportable operating segments sells all the product categories noted above. Accordingly, the only difference from the presentation above and our reportable operating segments are the geographic groupings.